University of Toronto - Hematological Pathology - Toronto

2022 R-1 Main Residency Match - first iteration
CMG Stream for CMG

Last approved on January 25, 2022

Summary of changes

Approximate Quota:


Accreditation status : Accredited

Provincial Criteria

Dr. David Barth
Laboratory Medicine and Pathobiology 
1 King's College Circle 
MSB, Rm 6231
Toronto, Ontario, M5S 1A8
(416) 978-7535
(416) 978-7361
Department of Laboratory Medicine and Pathobiology
PGME at U of T

Program Contacts

Program Contact
Paula Nixon
Postgraduate Coordinator

Important Information

Please be aware that most, if not all, hospitals and Universities in Ontario have mandatory COVID-19 vaccination policies in place that require, in the absence of a valid medical or human rights exemption, proof of vaccination. Acceptable vaccination must be in accordance with Health Canada. You will be required to provide documentation of COVID-19 vaccination to the appropriate institution if matched. Failure to comply and provide the appropriate documentation may result in the termination of the contract. These guidelines could change at any time in accordance with future direction from the Ministry of Health or the Universities based on information from Public Health.  

The Royal College of Physicians and Surgeons of Canada: Applying competency-based practices to residency education.

To contribute to the success of Canadian physicians and the delivery of high-quality patient care, the Royal College of Physicians and Surgeons of Canada has embarked upon an initiative to introduce competency-based medical education (CBME) in Canadian postgraduate specialty training and in professional practice in Canada. This initiative, called Competence by Design (CBD), aims to enhance patient care by aligning medical education and lifelong learning with evolving patient needs and empowering learners to more fully engage in their education process.

CBD will use time as a framework rather than the basis for progression. It is not anticipated that the duration of training will change for the majority of trainees. Residency programs will be broken down into stages, and each stage will have a series of milestones based on required competencies. These milestones will create more targeted learning outcomes and involve more frequent, formative assessments within the clinical workplace to ensure residents are developing and receiving feedback on the skills they need.

Hematological Pathology programs in Canada will adopt CBD in July 2022. Thus residents entering Hematological Pathology will experience CBD-based learning and assessment. As the adoption of this model is refined it will be enhanced to better reflect stakeholder needs.

All programs implementing CBD will continue to undergo the same rigorous accreditation processes as traditional programs. All CBD programs (and traditional programs) will continue to lead to Royal College approved certification. Certification for trainees in both CBD and traditional programs will include the completion of a Royal College examination; however, residents in CBD programs will also be assessed against program milestones throughout their training. Within a CBD program, all milestones (documented within an electronic portfolio) and the Royal College examination must be successfully completed to achieve certification.

General Instructions

Program application language: English

Thank you for your interest in the Postgraduate Education program in the Department of Hematological Pathology at The University of Toronto. This is the one of the largest Hematological Pathology residency programs in Canada in number of teaching staff, research productivity, hospital facilities and patient volume. (The University of Toronto is the tertiary referral centre for a metropolitan population of more than 2,600,000 and a surrounding population of about 6,000,000) These resources offer an unequalled opportunity for Hematological Pathology residency training. The very large research establishment and strong academic program provide a supportive environment for learning and enquiry in all aspects of Hematological Pathology.

Our program seeks to equip trainees to be the pathology leaders of the future.  Accordingly, we are looking for a cohort of residents that are committed to a career in pathology, keen to advance the evolving role of pathology in patient care and are capable of learning, understanding and integrating the large volume of material required.

The University of Toronto offers a comprehensive program in Hematological Pathology, which is accredited by the Royal College of Physicians and Surgeons of Canada. Over 20 staff hematological pathologists at multiple sites are involved in resident education. These sites include: The Hospital for Sick Children, Mount Sinai Hospital, St. Michael's Hospital, Sunnybrook Health Sciences Centre, Michael Garron Hospital, The University Health Network, Trillium Health Partners, LifeLabs and St. Joseph’s Health Centre. Each of these sites has particular strengths and allows the program as a whole to offer residents experience in all areas of Hematological Pathology practice.

  Visit our website at

Supporting Documentation

Canadian citizenship
CaRMS partners with third-party organizations to verify your citizenship or permanent resident status. If your status is verified by one of these organizations, you will not need to provide citizenship documents in your application. If your citizenship status is not verified, you must provide one of the documents listed below.
Document must be notarized/certified
Submit one of the following documents to verify your Canadian citizenship:
• Canadian Birth Certificate or Act of Birth
• Certificate of Canadian Citizenship
• Confirmation of Permanent Residence in Canada
• Passport page showing Canadian Citizenship
• Canadian Permanent Resident Card (both sides of card)
• Canadian Citizenship Card (both sides of card)

Legal Status

Proof of valid current citizenship or permanent resident status must be provided by submitting one of the following verifications to CaRMS by the File Review Opening deadline. Failure to provide valid proof will result in your application being removed. No other forms of verification are acceptable:

  1. Notarized/certified photocopy of Birth Certificate/Act of Birth issued by an authority in Canada accompanied by photo ID (must be Canadian government-issued photo ID).
  2. Documents must be notarized/certified photocopies. Notarized/certified copies must not be older than two years from the application submission deadline; otherwise, a new notarized/certified copy is required.
  3. Confirmation of permanent residence must be accompanied by a photo ID (must be a Canadian government-issued photo ID).

CaRMS is partnering with third-party organizations to automate the verification of citizenship/legal status required by postgraduate offices for entry into residency. Third-party verification simplifies the process for applicants and programs. All applicants who do not receive third-party citizenship verification will be required to upload and assign an acceptable proof of citizenship document. Please see additional information here.

Reference documents
Number requested: 3

Three references from teaching or attending staff are required.


Additional documents
Custom Résumé / CV 

Medical Student Performance Record 

Order from your Dean's Office.

Medical School Transcript 

Order from your Registrar

Personal Letter 
Word count
Minimum : None
Maximum : None

Please outline any personal history that may be relevant to your application. Also state your reasons for choosing Hematological Pathology as a career and outline your academic and non-academic accomplishments, as well as future goals.

Maximum word count: 1000 (no minimum)

[Note: Photograph is used as memory aid only]

Optional - will be reviewed
Advanced Cardiac Life Support (ACLS) 

If applicant is successful, ACLS is required before commencement of PGY1 clinical rotations. Please visit the PGME website for information on courses available through the University of Toronto.

MCCQE Part I - Statement of Results 

Review Process

Applications submitted after file review has opened on January 31, 2022

Supporting documents (excluding letters of reference) that arrive after file review has opened  on  January 31, 2022

Letters of reference that arrive after the unmasking date on January 31, 2022

Due to the high volume of applications we will NOT consider applications, reference letters or other supporting documents submitted after the file review has opened. 



  • March 2, 2022
Dates: March 2, 2022

After review of the application files we will offer interviews only to candidates that have made the interview short list. Candidates that are not contacted either by email or telephone have not made the list. Each candidate will meet with the Program Director and members of the Residency Training Committee.

Program will notify all applicants through CaRMS Online and will send email invitations directly to applicants selected for an interview.
Details regarding interview dates: March 2, 2022

Notification/Invitation: Program will only notify applicants who are selected for an interview.

Details regarding the interview process: Personal interviews are required.although exceptions will be made under special circumstances. The candidate will have a single interview with members of the Residency Training Committee. The interview format is informal; applicants will be asked to talk about themselves, their interests, reasons for their specialty choices, long term goals etc. Each interview is expected to last approximately 30-45 minutes. Interviews will take place via Zoom.


Selection Criteria

Program goals

Applicants providing evidence of high academic achievement, a demonstrated commitment to hematological pathology in particular, and evidence of research or similar academic potential in the CaRMS application file will be prioritized for further consideration. Successful applicants will be able to further elaborate their achievements at the time of interviews.

Upon completion of training, a resident is expected to be a competent specialist in Hematological Pathology capable of assuming a consultant’s role in the specialty. The resident must acquire a working knowledge of the theoretical basis of the specialty, including its foundations in science and research, as it applies to medical practice. The intent of a Hematological Pathology training program is to ensure that specialists in Hematological Pathology have the competence to act as consultants to clinicians with respect to appropriate investigation, diagnosis and monitoring of disorders of the blood cells, bone marrow, lymph nodes, spleen, and hemostasis. The resident is expected to be competent in all aspects of organizing and running a transfusion medicine service as well as to be competent in laboratory management issues of blood and blood product procurement and issuing. The resident will have a broad experience in both clinical and laboratory practice. The resident will understand the needs of laboratory Hematology in an adult, pediatric and community setting.

Selection process goals

Applicants providing evidence of high academic achievement, a demonstrated commitment to hematological pathology and evidence of research or similar academic potential in the CaRMS application file will be prioritized for further consideration. Successful applicants will be able to further elaborate their achievements at the time of interviews.

Candidates who fail to meet the level of academic achievement required or evidence of commitment to a career in hematological pathology will not be considered further. Other candidates will be ranked based on the scores of their application (50%) and interview (40%) and general fit with the program (10%). Final ranks will be determined solely by the aggregate score as outlined above.

File review process

Review team composition : Our review team is composed of the program director, site directors, senior hematological pathology resident and designated faculty members.

Average number of applications received by our program in the last five years : 51 - 200

Average percentage of applicants offered interviews : 0 - 25 %

Evaluation criteria :
File component Criteria
CV We evaluate all content including research, publications, volunteer activities and interests
Electives We recognize that the COVID-19 pandemic has impacted candidates’ opportunities to arrange and complete electives and would like to reassure you that a lack of elective activity this year will not negatively impact your application to our program.
Examinations We evaluate all examination results.
Extra-curricular We evaluate all activities including mentoring and volunteer activities
Leadership skills We evaluate leadership positions and programs that develop leadership skills
MSPRs We evaluate all past performance including undergraduate and graduate studies.
Personal letters We evaluate interest in, and dedication to, hematological pathology and our program.
Reference documents We evaluate all reference letters for evidence of excellence in CanMEDS roles.
Research/Publications We evaluate participation in, and dedication to, research activties including publications.
Transcripts We evaluate all academic performance.

Elective criteria

We recognize that the COVID-19 pandemic has impacted candidates’ opportunities to arrange and complete electives and would like to reassure you that a lack of elective activity this year will not negatively impact your application to our program.
We do not require applicants to have done onsite electives.

Interview process

Interview format :

We routinely accommodate requests to re-schedule interviews for applicants.

Interview evaluation criteria :
Interview components Criteria
Collaboration skills We evaluate the ability to work in a team environment to provide exemplary care.
Collegiality We evaluate behaviour, attitudes and professionalism as demonstrated by the candidate.
Communication skills We evaluate proficiency in effective written and spoken English within a team environment
Health advocacy We evaluate dedication to health advocacy.
Interest in the discipline We evaluate interest & dedication to the knowledge and skills required to practice HP
Interest in the program We evaluate interest and commitment to our Hematological Pathology Residency Training Program
Leadership skills We evaluate a commitment to developing leadership skills required for a hematopathology practice.
Professionalism We evaluate the ability to demonstrate professional conduct at all times.
Scholarly activities We evaluate all scholarly activity including research and teaching
Other interview component(s)  

Information gathered outside of CaRMS application

We do not consider any information gathered outside of the CaRMS application and local interview processes.

Ranking process

The behavior(s) exhibited below during the interview process may prevent an applicant from being ranked by our program :

Program Highlights

  • Wide spectrum of clinical material from routine to very rare cases.
  •  Multiple training sites within the program allows residents to see different practice patterns, sites that have particular expertise in subsections of hematologic pathology, train with different staff that have particular expertise in subsections of hematologic pathology.
  • Ability to train across all disciplines of hematologic pathology on site.
  • High faculty to resident ratio.
  • Opportunity for interprovincial and international electives.
  • Research opportunities are very wide given spectrum of clinical activity and relationships with multiple research institutions associated with the University and Hospital Research Centres.
  • Weekly Academic Half Days covering wide spectrum of topics. Inclusion of Hematologic Pathology residents in the University of Toronto Clinical Hematology Academic Half Days and other Hematology teaching rounds

Program Curriculum

This residency program is for 4 years.

Program length of training does not exceed the Royal College or College of Family Physicians of Canada standard.

Hematological Pathology is a four year program. The four year program is structured to meet the requirements of the Royal College of Physicians and Surgeons of Canada. 

Starting in July, 2022, all PGY1 residents in Hematological Pathology residency training programs throughout Canada will implement a Competence By Design (CBD) curriculum format. This is a Competency Based Medical Education system instituted by the Royal College of Physicians and Surgeons of Canada. CBD will mainly reflect changes in the way residents are coached, assessed and promoted throughout their residency. Under CBD, the residency is divided into four stages: Transition to Discipline, Foundations of Discipline, Core of Discipline, and Transition to Practice

The first stage for residents is Transition to Discipline (TTD), which will include an orientation Hematological Pathology.

Foundations of Discipline (FOD), the second stage of the continuum of residency education, is when the basics are taught, learned, assessed, and demonstrated.

Core of Discipline (COD) is the third stage of the continuum of residency education and is the longest stage of training. During this stage, the resident will complete various Hematological Pathology rotations to gain competence in the diagnosis and monitoring of disorders of blood cells, bone marrow, lymph nodes, spleen and hemostasis. It is anticipated that in the future the specialty exam will be administered near the end of the Core stage.

The fourth and final stage of residency education is Transition to Practice (TTP), which focuses on ensuring residents’ confidence and competence to practice within their discipline. This stage occurs after the completion of the RC exams to allow the resident some flexibility to complete research projects and rotations of particular interest.

Hematological Pathology Research

The resident will be expected to undertake a research project under the supervision of a faculty member. The research project can be at the basic science or clinical laboratory level. There are extensive opportunities for research within the department.

Academic Program

Seminars and an organized teaching program supplement residency training. Centralized and hospital-based seminars and rounds are held regularly, as well as graduate and joint interdepartmental seminars which residents are encouraged to attend. An academic half-day each week is an integral part of the program.


Since July 1, 2008 all University of Toronto Residents entering PGY1 are required to complete the web based PGCorEd* core competency modules as part of their residency program certification. These modules provide the foundation for non-clinical roles for the RCPSC and CFPC Programs. These modules are focused for PGY 1 & PGY2 trainees. Failure to complete the modules will delay processing of Final In-Training Evaluation Reports (FITERs) and may constitute professional misconduct.

Training Sites

The university division of Hematopathology has staff and facilities at Mount Sinai Hospital, Sunnybrook Health Sciences Centre, The University Health Network, The Hospital for Sick Children, Unity Health, Michael Garron Hospital, LifeLabs and Trillium Health Partners. The training program, however, operates as a single unit. The facilities provided in the four major teaching hospitals are extensive. The volume in the combined hospitals is larger than any other centre in Canada. In all these hospitals the entire spectrum of hematological pathology is available for resident teaching. There is a wide array of different instrumentation and technology used so the resident has exposure to a range of procedures.

Additional Information

  1. Permanent Residents: Successful applicants who hold Permanent Resident status in Canada will be required to disclose their Country of Citizenship to the postgraduate medical education office in order to comply with current reporting requirements of the Ontario Ministry of Colleges and Universities
  2. Matched applicants: CaRMS will provide their electronic data file to the matched university’s postgraduate education office. The postgraduate office will share the information as needed, but not limited to, the Ontario Physician Human Resource Data Centre, Canadian Post-MD Education Registry, the College of Physicians and Surgeons of Ontario, the Royal College of Physicians and Surgeons, the College of Family Physicians of Canada, the Association of Faculties of Medicine of Canada, the Professional Association of Residents of Ontario, teaching hospitals and other training sites, Touchstone Institute and the Ontario Ministry of Health.
  3. Changes: The Ontario Faculties of Medicine and Ontario Ministry of Health reserve the right to make changes to the information published on the CaRMS website pertaining to Ontario postgraduate training without prior notice.
  4. Failure to meet or provide proof of any of the stated requirements may result in the applicant file not being reviewed and removed.

Summary of changes

SUMMARY ID Section Summary of changes Updated on NOTIFY APPLICANTS SECTION NAME Actions